Nationwide and Florida Pradaxa Deaths
Our Personal Injury Lawyers Litigate Defective Pharmaceutical Claims
The FDA approved Pradaxa in October 2010 for treatment of atrial fibrillation. At the time, the medication was marketed as a wonder drug and a more convenient alternative to warfarin. Within only a few months, problems with the anticoagulant medication became apparent. Patients experienced internal bleeding, hemorrhaging and other adverse health issues after taking Pradaxa. Many patients suffered permanent disabilities and many more sustained fatal injuries because of uncontrolled bleeding that could not be stopped by vitamin K injections or other common treatments.
To date, Pradaxa has not been recalled. However, the FDA is investigating the potential risks of injury and death linked to the blood-thinner and has issued alerts notifying the public of serious bleeding events in Pradaxa users.
Searcy, Denney, Scarola, Barnhart & Shipley, P.A. was established in 1979 to help injured patients recover compensation from negligent medical device and pharmaceutical manufacturers. We regularly represent families of victims killed by defective drugs and medical products.
Deaths Linked to Pradaxa
More than 1,400 fatalities in the United States have been linked to Pradaxa. Unfortunately, more patients are likely to die before Boehringer Ingelheim Pharmaceuticals, Inc. finally pulls the drug from the market or the FDA takes action. Even when patients receive immediate, adequate medical treatment, often doctors can do nothing to stop the bleeding in Pradaxa patients. For this reason, even mild injuries can turn deadly. For example:
- A 92-year old Texan died of gastric ulcer bleeding after taking Pradaxa for just one day.
- A South Florida Pradaxa death occurred when the patient suffered uncontrollable GI bleeding.
- A Pradaxa user in Utah experienced irreversible brain hemorrhage arising from a minor bump to his head.
- A healthy 80-year old Texas woman died of fatal intracranial hemorrhaging within 24 hours of falling and hitting her head because Pradaxa kept the woman’s blood from clotting.
Until courts ordered the release of vital documents, Boehringer Ingelheim Pharmaceuticals, Inc. refused to disclose data that indicated the company knew about the fatal bleeding risks associated with Pradaxa.
Pradaxa Wrongful Death Claims
Our firm files Florida Pradaxa death claims and lawsuits arising in states throughout the country in multidistrict litigation (MDL) in Illinois. MDL streamlines the claims to expedite the process, reduce expenses and produce more consistent results. MDL is not a class action, but rather individual wrongful death and products liability claims consolidated into one proceeding. The Searcy Denney Mass Tort Unit has the experience and extensive resources to effectively handle MDL claims.
Furthermore, we understand the heartache family members endure after needlessly losing a loved one. We know we can never erase this pain. However, we pursue justice by striving to hold Boehringer Ingelheim Pharmaceuticals, Inc. accountable for its actions.
Learn More About Filing a Lawsuit in a Florida Pradaxa Death Claim
If your loved one died because of uncontrolled bleeding associated with Pradaxa use, you can take legal action against the drug manufacturing company. Call Searcy Denney at 800.780.8607 to discuss filing a wrongful death claim—you can also fill out our consultation form. The initial evaluation of your case is complimentary.